Clorox (NYSE:CLX) Price Target Lowered to $110.00 at Morgan Stanley

Clorox (NYSE:CLX) had its target price lowered by Morgan Stanley from $136.00 to $110.00 in a research report released on Wednesday,MarketScreener reports. The firm currently has an equal weight rating on the stock.

A number of other research analysts also recently issued reports on the stock. BNP Paribas Exane upgraded shares of Clorox from an “underperform” rating to a “neutral” rating in a research report on Wednesday, February 11th. Wall Street Zen upgraded shares of Clorox from a “sell” rating to a “hold” rating in a research report on Saturday, February 7th. Citigroup reduced their price target on shares of Clorox from $115.00 to $110.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 15th. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Clorox from $101.00 to $100.00 and set a “hold” rating on the stock in a research report on Monday. Finally, Jefferies Financial Group reduced their price target on shares of Clorox from $151.00 to $139.00 and set a “buy” rating on the stock in a research report on Tuesday. One analyst has rated the stock with a Buy rating, twelve have given a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus target price of $111.33.

Clorox Trading Down 2.8%

NYSE CLX opened at $96.78 on Wednesday. Clorox has a 12 month low of $96.58 and a 12 month high of $143.96. The company has a debt-to-equity ratio of 71.03, a current ratio of 0.74 and a quick ratio of 0.48. The company has a market capitalization of $11.70 billion, a price-to-earnings ratio of 15.81, a price-to-earnings-growth ratio of 0.49 and a beta of 0.65. The company’s fifty day moving average price is $111.48 and its two-hundred day moving average price is $109.70.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.04). Clorox had a return on equity of 383.01% and a net margin of 11.17%.The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the previous year, the business posted $1.55 earnings per share. The company’s quarterly revenue was down .8% compared to the same quarter last year. As a group, research analysts predict that Clorox will post 5.89 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 8th. Investors of record on Wednesday, April 22nd will be given a $1.24 dividend. The ex-dividend date is Wednesday, April 22nd. This represents a $4.96 annualized dividend and a yield of 5.1%. Clorox’s dividend payout ratio (DPR) is currently 81.05%.

Institutional Trading of Clorox

Several hedge funds have recently bought and sold shares of the company. Tred Avon Family Wealth LLC bought a new stake in Clorox in the 1st quarter valued at about $663,000. Apollon Wealth Management LLC lifted its position in Clorox by 15.4% in the 1st quarter. Apollon Wealth Management LLC now owns 4,777 shares of the company’s stock valued at $495,000 after purchasing an additional 637 shares during the last quarter. Coston McIsaac & Partners lifted its position in Clorox by 17.8% in the 1st quarter. Coston McIsaac & Partners now owns 35,601 shares of the company’s stock valued at $3,689,000 after purchasing an additional 5,379 shares during the last quarter. Patton Fund Management Inc. lifted its position in Clorox by 28.6% in the 1st quarter. Patton Fund Management Inc. now owns 2,815 shares of the company’s stock valued at $292,000 after purchasing an additional 626 shares during the last quarter. Finally, Janney Montgomery Scott LLC lifted its position in Clorox by 48.1% in the 1st quarter. Janney Montgomery Scott LLC now owns 163,848 shares of the company’s stock valued at $16,980,000 after purchasing an additional 53,209 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Key Stories Impacting Clorox

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Jefferies kept a “buy” rating and, despite trimming its price target to $139, still implies substantial upside versus current levels — a supportive note for long-term investors who prioritize upside potential. Jefferies trims PT but stays buy Additional coverage TickerReport
• Positive Sentiment: A Seeking Alpha piece highlights CLX’s very low valuation relative to history and its highest dividend since 1983, framing the stock as attractive to income and value investors if fundamentals stabilize. Clorox valuation/dividend article
• Neutral Sentiment: Yahoo Finance ran a broader story on cash-generating companies that still fall short because of poor capital allocation; if Clorox is mentioned, it reinforces investor focus on how management deploys cash (dividends, buybacks, M&A) rather than raw cash flow alone. 3 Cash-Producing Stocks That Fall Short
• Negative Sentiment: Morgan Stanley cut its price target to $110 and moved to “equal weight,” reducing upside expectations and signaling less conviction in near-term upside. Morgan Stanley PT cut
• Negative Sentiment: Deutsche Bank lowered its price target to $100, another bearish data point that tightens the range of analyst expectations and likely pressures sentiment. Deutsche Bank lowers PT to $100
• Negative Sentiment: Analyst consensus has shifted toward a “Reduce”/downgrade posture per American Banking News, contributing to selling pressure as multiple firms trim expectations. Analysts average “Reduce”

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.